JP2023509698A5 - - Google Patents
Info
- Publication number
- JP2023509698A5 JP2023509698A5 JP2022541198A JP2022541198A JP2023509698A5 JP 2023509698 A5 JP2023509698 A5 JP 2023509698A5 JP 2022541198 A JP2022541198 A JP 2022541198A JP 2022541198 A JP2022541198 A JP 2022541198A JP 2023509698 A5 JP2023509698 A5 JP 2023509698A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- compound
- individual
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062957535P | 2020-01-06 | 2020-01-06 | |
| US62/957,535 | 2020-01-06 | ||
| PCT/US2021/012367 WO2021142030A1 (en) | 2020-01-06 | 2021-01-06 | Methods of treating conditions related to the s1p1 receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023509698A JP2023509698A (ja) | 2023-03-09 |
| JP2023509698A5 true JP2023509698A5 (https=) | 2023-12-26 |
Family
ID=76788331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022541198A Pending JP2023509698A (ja) | 2020-01-06 | 2021-01-06 | Ｓ１ｐ１受容体に関連した状態の処置方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230338336A1 (https=) |
| EP (1) | EP4087562A4 (https=) |
| JP (1) | JP2023509698A (https=) |
| KR (1) | KR20220124209A (https=) |
| CN (1) | CN115066242A (https=) |
| AU (1) | AU2021205465A1 (https=) |
| BR (1) | BR112022012846A2 (https=) |
| CA (1) | CA3166828A1 (https=) |
| IL (1) | IL294071A (https=) |
| MX (1) | MX2022008342A (https=) |
| TW (1) | TW202135804A (https=) |
| WO (1) | WO2021142030A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4404930A1 (en) * | 2021-09-23 | 2024-07-31 | Bristol-Myers Squibb Company | Methods of treating hair-loss disorders with tyk2 inhibitors |
| KR20240134360A (ko) * | 2022-01-13 | 2024-09-09 | 아레나 파마슈티칼스, 인크. | 호르몬 치료와 조합되어 s1p1 수용체-연관된 장애를 치료하는 데 사용하기 위한 에트라시모드 |
| CN118234492A (zh) * | 2022-10-21 | 2024-06-21 | 次代生物科学株式会社 | 具有针对s1pr1和s1pr4的功能性抑制剂作用的用于预防或治疗圆形脱发症的药物组合物 |
| KR102541577B1 (ko) * | 2022-10-21 | 2023-06-13 | 주식회사 넥스트젠바이오사이언스 | S1pr1과 s1pr4에 대한 기능적 저해제로 작용하는 원형 탈모증의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003061567A2 (en) * | 2002-01-18 | 2003-07-31 | Merck & Co., Inc. | Selective s1p1/edg1 receptor agonists |
| US8580841B2 (en) * | 2008-07-23 | 2013-11-12 | Arena Pharmaceuticals, Inc. | Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| MX2012005560A (es) * | 2009-11-13 | 2012-10-05 | Receptos Inc | Moduladores selectivos del receptor de esfingosina 1 fosfato y metodos de sintesis quiral. |
| ES2665461T3 (es) * | 2009-11-13 | 2018-04-25 | Celgene International Ii Sàrl | Moduladores del receptor esfingosina 1-fosfato y métodos de síntesis quiral |
| PH12012500940B1 (en) * | 2009-11-13 | 2018-09-26 | Receptos Llc | Selective heterocyclic sphingosine 1 phosphate receptor modulators |
| US9198911B2 (en) * | 2010-11-02 | 2015-12-01 | The Trustees Of Columbia University In The City Of New York | Methods for treating hair loss disorders |
| PL3242666T3 (pl) * | 2015-01-06 | 2025-02-17 | Arena Pharmaceuticals, Inc. | Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1 |
| MX2019009841A (es) * | 2017-02-16 | 2020-01-30 | Arena Pharm Inc | Compuestos y metodos para el tratamiento de la colangitis biliar primaria. |
-
2021
- 2021-01-06 AU AU2021205465A patent/AU2021205465A1/en not_active Abandoned
- 2021-01-06 US US17/790,632 patent/US20230338336A1/en not_active Abandoned
- 2021-01-06 TW TW110100496A patent/TW202135804A/zh unknown
- 2021-01-06 MX MX2022008342A patent/MX2022008342A/es unknown
- 2021-01-06 CA CA3166828A patent/CA3166828A1/en active Pending
- 2021-01-06 EP EP21738729.9A patent/EP4087562A4/en not_active Withdrawn
- 2021-01-06 BR BR112022012846A patent/BR112022012846A2/pt not_active IP Right Cessation
- 2021-01-06 JP JP2022541198A patent/JP2023509698A/ja active Pending
- 2021-01-06 CN CN202180013704.0A patent/CN115066242A/zh not_active Withdrawn
- 2021-01-06 KR KR1020227026729A patent/KR20220124209A/ko not_active Withdrawn
- 2021-01-06 IL IL294071A patent/IL294071A/en unknown
- 2021-01-06 WO PCT/US2021/012367 patent/WO2021142030A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023509698A5 (https=) | ||
| JP7128536B2 (ja) | 特定の患者集団において神経変性障害を処置する方法 | |
| JP5344620B2 (ja) | オルメサルタンメドキソミル及びアムロジピンの固形製剤 | |
| US20050187262A1 (en) | Compositions comprising (S)-amlodipine and an angiotensin receptor blocker and methods of their use | |
| JP2022516662A5 (https=) | ||
| TW200412934A (en) | Pharmaceutical formulations of modafinil | |
| US5661171A (en) | Controlled release pilocarpine delivery system | |
| JP3929618B2 (ja) | 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物 | |
| EP4289478A2 (en) | Edaravone pharmaceutical composition | |
| JP2022533968A5 (https=) | ||
| JP2013121976A (ja) | 難溶性薬剤の改善された溶解プロファイルを有する医薬組成物 | |
| US20110230552A1 (en) | Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack | |
| JP2021152060A (ja) | アカンプロセートおよびｄ−サイクロセリンを使用する組み合わせ療法 | |
| JP2024531188A5 (https=) | ||
| WO2005094832A1 (en) | Compositions comprising meloxicam | |
| AU2003287488B2 (en) | Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or bucally | |
| JP2005518435A (ja) | 口腔及び咽頭腔における疼痛状態の治療用アンブロキソール | |
| JP3170855B2 (ja) | イブプロフェン含有解熱鎮痛剤 | |
| EP3600276B1 (en) | Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject | |
| WO2021171318A1 (en) | Transmucosal pharmaceutical composition of levocetirizine | |
| JP4113257B2 (ja) | 口腔乾燥症の処理におけるコリンエステラーゼ阻害剤の使用 | |
| JPH07126163A (ja) | 制御放出性ピロカルピン送達システム | |
| MX2013005716A (es) | Formulacion de un complejo que comprende clorhidrato de lercanidipina y valsartan y metodo para la preparacion de la misma. | |
| JP2002523363A (ja) | 慢性疲労症候群および／または線維筋痛の処置のためのサブスタンスｐアンタゴニストの使用および慢性疲労症候群の処置のためのｎｋ−１レセプターアンタゴニストの使用 | |
| HUP0100365A2 (hu) | Kombinációs terápia AIDS kezelésére |